SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : T/FIF Portfolio -- Ignore unavailable to you. Want to Upgrade?


To: Russian Bear who wrote (194)11/4/1998 12:25:00 PM
From: scaram(o)uche  Read Replies (2) | Respond to of 1073
 
RB.... even comes inclusive with an email address......

Nat Biotechnol 1998 Sep;16(9):862-6

Functional gene transfer from intracellular bacteria to mammalian cells.

Grillot-Courvalin C, Goussard S, Huetz F, Ojcius DM, Courvalin P

Unite des Agents Antibacteriens, Institut Pasteur, Paris, France. ccourval@pasteur.fr

We provide evidence of direct transfer of functional DNA from bacteria to mammalian cells. An Escherichia coli K12
diaminopimelate auxotroph made invasive by cloning the invasin gene from Yersinia pseudotuberculosis transfers DNA after
simple co-incubation, into a variety of mammalian cell lines. Transfer efficiency was enhanced in some cells by coexpression of
the gene for listeriolysin from Listeria monocytogenes. Expression of the acquired genes occurs in both dividing and quiescent
cells. The only requirement for bacteria to transfer genetic material into nonprofessional phagocytic cells and macrophages is the
ability to invade the host cell.



To: Russian Bear who wrote (194)11/5/1998 8:30:00 AM
From: jayhawk969  Read Replies (2) | Respond to of 1073
 
RB,

If I recall correctly, Ontak (formerly Seragen's drug waiting for approval, and now owned by Ligand), is a fermented E-Coli with attached proteins. This appears to be their approach with other targets in the offing.

J.D.